FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023186997> ?p ?o ?g. }

• W2023186997 abstract "Abstract Background Activation of peroxisome proliferator-activated receptors γ (PPARγ) induces diverse effects on cancer cells. The thiazolidinediones (TZDs), such as troglitazone and ciglitazone, are PPARγ agonists exhibiting antitumor activities; however, the underlying mechanism remains inconclusive. Rosiglitazone (RGZ), a synthetic ligand of PPARγ used in the treatment of Type 2 diabetes, inhibits growth of some tumor cells and is involved in other processes related to cancer progression. Opposing results have also been reported with different ligands on tumor cells. The purpose of this study was to determine if RGZ and 15d-PGJ 2 induce antitumor effects in vivo and in vitro on the murine mammary tumor cell line LMM3. Methods The effect on LMM3 cell viability and nitric oxide (NO) production of different doses of RGZ, 15-dPGJ 2 , BADGE and GW9662 were determined using the MTS colorimetric assay and the Griess reaction respectively. In vivo effect of orally administration of RGZ on tumor progression was evaluated either on s.c. primary tumors as well as on experimental metastasis. Cell adhesion, migration (wound assay) and invasion in Transwells were performed. Metalloproteinase activity (MMP) was determined by zymography in conditioned media from RGZ treated tumor cells. PPARγ expression was detected by inmunohistochemistry in formalin fixed tumors and by western blot in tumor cell lysates. Results RGZ orally administered to tumor-bearing mice decreased the number of experimental lung metastases without affecting primary s.c. tumor growth. Tumor cell adhesion and migration, as well as metalloproteinase MMP-9 activity, decreased in the presence of 1 μM RGZ (non-cytotoxic dose). RGZ induced PPARγ protein expression in LMM3 tumors. Although metabolic activity -measured by MTS assay- diminished with 1–100 μM RGZ, 1 μM-treated cells recovered their proliferating capacity while 100 μM treated cells died. The PPARγ antagonist Biphenol A diglicydyl ether (BADGE) did not affect RGZ activity. On the contrary, the specific antagonist GW9662 completely abrogated RGZ-induced decrease in cell viability. A decrease in NO levels was detected in the presence of either 1 or 100 μM RGZ. The natural ligand 15d-PGJ 2 did not affect metabolic activity although it induced a significant decrease in NO production. Conclusion A significant decrease in the number of experimental LMM3 lung metastasis, but not on primary tumor growth, after oral RGZ administration was observed. In vitro , 100 μMRGZ also reduced cell viability and NO production, while no changes were observed in the presence of 15d-PGJ 2 . BADGE did not reverse RGZ effect while the antagonist GW9662 completely abrogated it, suggesting a PPARγ- dependent mechanism. Inhibition of lung metastatic nodules by RGZ administered in vivo, might be associated with the observed decrease in MMP-9 expression, in cell adhesion, migration and invasion. RGZ augmented its expression. PPARγ was detected in cell lysates by western blot and by immunohistochemistry in tumors from RGZ-treated mice. In summary we can suggest that RGZ or any other TZDs might be possible future approaches in the treatment of metastasis of PPARγ-expressing cells." @default.
• W2023186997 created "2016-06-24" @default.
• W2023186997 creator A5015008409 @default.
• W2023186997 creator A5022131154 @default.
• W2023186997 creator A5065658372 @default.
• W2023186997 creator A5086670214 @default.
• W2023186997 date "2008-02-08" @default.
• W2023186997 modified "2023-10-18" @default.
• W2023186997 title "Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3" @default.
• W2023186997 cites W1492228142 @default.
• W2023186997 cites W1580962701 @default.
• W2023186997 cites W1633340712 @default.
• W2023186997 cites W1963500461 @default.
• W2023186997 cites W1969161886 @default.
• W2023186997 cites W1970474244 @default.
• W2023186997 cites W1981556606 @default.
• W2023186997 cites W1990924583 @default.
• W2023186997 cites W1995975692 @default.
• W2023186997 cites W2008296807 @default.
• W2023186997 cites W2018661263 @default.
• W2023186997 cites W2022569535 @default.
• W2023186997 cites W2045266101 @default.
• W2023186997 cites W2048030108 @default.
• W2023186997 cites W2052990800 @default.
• W2023186997 cites W2059030487 @default.
• W2023186997 cites W2064974844 @default.
• W2023186997 cites W2069412024 @default.
• W2023186997 cites W2084582367 @default.
• W2023186997 cites W2093468104 @default.
• W2023186997 cites W2094961418 @default.
• W2023186997 cites W2101973145 @default.
• W2023186997 cites W2131947466 @default.
• W2023186997 cites W2136136285 @default.
• W2023186997 cites W2157697601 @default.
• W2023186997 cites W2171561094 @default.
• W2023186997 cites W4232537562 @default.
• W2023186997 doi "https://doi.org/10.1186/1471-2407-8-47" @default.
• W2023186997 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2268944" @default.
• W2023186997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18261208" @default.
• W2023186997 hasPublicationYear "2008" @default.
• W2023186997 type Work @default.
• W2023186997 sameAs 2023186997 @default.
• W2023186997 citedByCount "27" @default.
• W2023186997 countsByYear W20231869972012 @default.
• W2023186997 countsByYear W20231869972015 @default.
• W2023186997 countsByYear W20231869972016 @default.
• W2023186997 countsByYear W20231869972018 @default.
• W2023186997 countsByYear W20231869972022 @default.
• W2023186997 crossrefType "journal-article" @default.
• W2023186997 hasAuthorship W2023186997A5015008409 @default.
• W2023186997 hasAuthorship W2023186997A5022131154 @default.
• W2023186997 hasAuthorship W2023186997A5065658372 @default.
• W2023186997 hasAuthorship W2023186997A5086670214 @default.
• W2023186997 hasBestOaLocation W20231869971 @default.
• W2023186997 hasConcept C109523444 @default.
• W2023186997 hasConcept C121608353 @default.
• W2023186997 hasConcept C126322002 @default.
• W2023186997 hasConcept C134018914 @default.
• W2023186997 hasConcept C1491633281 @default.
• W2023186997 hasConcept C150903083 @default.
• W2023186997 hasConcept C170493617 @default.
• W2023186997 hasConcept C177430391 @default.
• W2023186997 hasConcept C187345961 @default.
• W2023186997 hasConcept C207001950 @default.
• W2023186997 hasConcept C2776923340 @default.
• W2023186997 hasConcept C2777180221 @default.
• W2023186997 hasConcept C2778150266 @default.
• W2023186997 hasConcept C2779013556 @default.
• W2023186997 hasConcept C2779256057 @default.
• W2023186997 hasConcept C2780152017 @default.
• W2023186997 hasConcept C2780963305 @default.
• W2023186997 hasConcept C502942594 @default.
• W2023186997 hasConcept C53227056 @default.
• W2023186997 hasConcept C54355233 @default.
• W2023186997 hasConcept C55493867 @default.
• W2023186997 hasConcept C555293320 @default.
• W2023186997 hasConcept C62112901 @default.
• W2023186997 hasConcept C71924100 @default.
• W2023186997 hasConcept C81885089 @default.
• W2023186997 hasConcept C86803240 @default.
• W2023186997 hasConcept C98274493 @default.
• W2023186997 hasConceptScore W2023186997C109523444 @default.
• W2023186997 hasConceptScore W2023186997C121608353 @default.
• W2023186997 hasConceptScore W2023186997C126322002 @default.
• W2023186997 hasConceptScore W2023186997C134018914 @default.
• W2023186997 hasConceptScore W2023186997C1491633281 @default.
• W2023186997 hasConceptScore W2023186997C150903083 @default.
• W2023186997 hasConceptScore W2023186997C170493617 @default.
• W2023186997 hasConceptScore W2023186997C177430391 @default.
• W2023186997 hasConceptScore W2023186997C187345961 @default.
• W2023186997 hasConceptScore W2023186997C207001950 @default.
• W2023186997 hasConceptScore W2023186997C2776923340 @default.
• W2023186997 hasConceptScore W2023186997C2777180221 @default.
• W2023186997 hasConceptScore W2023186997C2778150266 @default.
• W2023186997 hasConceptScore W2023186997C2779013556 @default.
• W2023186997 hasConceptScore W2023186997C2779256057 @default.
• W2023186997 hasConceptScore W2023186997C2780152017 @default.
• W2023186997 hasConceptScore W2023186997C2780963305 @default.
• W2023186997 hasConceptScore W2023186997C502942594 @default.
• W2023186997 hasConceptScore W2023186997C53227056 @default.

• next